No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathy

Edgar T. Hoorntje, Anna Posafalvi, Petros Syrris, K. Joeri Van Der Velde, Marieke C. Bolling, Alexandros Protonotarios, Ludolf G. Boven, Nuria Amat-Codina, Judith A. Groeneweg, Arthur A. Wilde, Nara Sobreira, Hugh Calkins, Richard N.W. Hauer, Marcel F. Jonkman, William J. McKenna, Perry M. Elliott, Richard J. Sinke, Maarten P. Van Den Berg, Stephen P. Chelko, Cynthia A. JamesJ. Peter Van Tintelen, Daniel P. Judge, Jan D.H. Jongbloed

Research output: Contribution to journalArticlepeer-review

Abstract

Aims Likely pathogenic/pathogenic variants in genes encoding desmosomal proteins play an important role in the pathophysiology of arrhythmogenic right ventricular cardiomyopathy (ARVC). However, for a substantial proportion of ARVC patients, the genetic substrate remains unknown. We hypothesized that plectin, a cytolinker protein encoded by the PLEC gene, could play a role in ARVC because it has been proposed to link the desmosomal protein desmoplakin to the cytoskeleton and therefore has a potential function in the desmosomal structure. Methods We screened PLEC in 359 ARVC patients and compared the frequency of rare coding PLEC variants (minor allele frequency [MAF] <0.001) between patients and controls. To assess the frequency of rare variants in the control population, we evaluated the rare coding variants (MAF <0.001) found in the European cohort of the Exome Aggregation Database. We further evaluated plectin localization by immunofluorescence in a subset of patients with and without a PLEC variant. Results Forty ARVC patients carried one or more rare PLEC variants (11%, 40/359). However, rare variants also seem to occur frequently in the control population (18%, 4754/26197 individuals). Nor did we find a difference in the prevalence of rare PLEC variants in ARVC patients with or without a desmosomal likely pathogenic/pathogenic variant (14% versus 8%, respectively). However, immunofluorescence analysis did show decreased plectin junctional localization in myocardial tissue from 5 ARVC patients with PLEC variants. Conclusions Although PLEC has been hypothesized as a promising candidate gene for ARVC, our current study did not show an enrichment of rare PLEC variants in ARVC patients compared to controls and therefore does not support a major role for PLEC in this disorder. Although rare PLEC variants were associated with abnormal localization in cardiac tissue, the confluence of data does not support a role for plectin abnormalities in ARVC development.

Original languageEnglish (US)
Article numbere0203078
JournalPloS one
Volume13
Issue number8
DOIs
StatePublished - Aug 2018

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Fingerprint Dive into the research topics of 'No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathy'. Together they form a unique fingerprint.

Cite this